MiR-125b-5p alleviates pulmonary fibrosis by inhibiting epithelial-mesenchymal transition via targeting BAK1

This study explores the role and potential mechanisms of microRNA-125b-5p (miR-125b-5p) in pulmonary fibrosis (PF). PF is a typical outcome of many chronic lung diseases, with poor prognosis and the lack of appropriate medical treatment because molecular mechanisms of PF remain poorly understood. In this study, using in vitro and in vivo analyses, we find that miR-125b-5p is likely a potent regulator of lung fibrosis.